| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.071 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |